Diabetes is a leading cause of death and disability in the worldwide. It increases the risk for heart disease, end-stage renal disease, blindness, amputation, and complications of pregnancy and is ranked as the sixth leading cause of death. Disease prevalence is driving sales of monitoring equipment. The glucose monitoring device and diabetes management market is focused on utilizing advancements recently introduced to provide easier-to-use products and more accurate glucose monitoring.
This Kalorama information report, The Global Glucose Monitoring Market provides market estimates and forecasts for this important test category. As part of its coverage, the report breaksout the revenues earned by the glucose monitoring industry into appropriate segments so that businesses can assess the right market opportunity for the area they compete in. The report includes estimates and forecasts for the following segments:
- Traditional Glucose Monitoring Devices
- Test Strips
- Glycated Hemoglobin Devices
- Continuous Glucose Monitoring Devices
- HbA1c and other Market
There are many issues facing this industry. Some issues are helping to propel the market; while other issues are retarding growth forward. Issues and trends driving the market for glucose monitoring devices and diabetes management include: New innovations, Reimbursement challenges, Recalls, Aging of the population, Increasing life expectancy, Healthcare spending trends, Advances in sensors, Health insurance portability, Cost cutting, Healthcare efficiency, Capacity challenges, Growing acceptance of mobile technologies and other factors. These are discussed at length in the report, as are their role in market growth.
In this global report, Kalorama identifies market size and forecast for Traditional Glucose Monitoring and Continuous Glucose Monitoring (CGM) both worldwide and for the following countries and regions:
- United States
Although there are many participants in the market, a handful of companies continue to make a significant impact on the glucose monitoring devices and diabetes management market. A select few are discussed here, including:
- Abbott Laboratories
- Arkray, Inc
- Bayer Diabetes
- Bionime Corporation
- DexCom, Inc.
- Echo Therapeutics
- Entra Health Systems LLC
- Fora Care, Inc
- Genesis Health Technologies
- GlySure Limited
- Johnson & Johnson
- Nipro Diagnostics, Inc
- Nova Diabetes Care, Inc.
- Oak Tree International Holdings, Inc.
- Prodigy Diabetes Care, LLC
- U.S. Diagnostics, Inc.
Telephone interviews and email correspondence were the primary method of gathering information. For the purpose of this study, Kalorama Information conducted interviews with more than 14 key industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Specific interviews with company representatives included marketing directors, division managers, and product representatives.
Additionally, Kalorama Information has nearly a decade of compiled industry contacts, technology knowledge and industry experience reporting on the patient management market segment, a market with parallel industry dynamics.Secondary sources such as company literature, databases, investment reports, and medical, information technology and business journals were used to complement primary information. Databases covering patient billings and units sold were significant resources for validating primary findings.